Back

Analysis of the genetic diversity of SARS-CoV-2 genomes carrying the Omicron B.1.1.529 mutation

Silva, B. W. C. d.; Felix, P. T.

2022-05-25 infectious diseases
10.1101/2022.05.21.22275421 medRxiv
Show abstract

In this work, we evaluated the levels of genetic diversity in 95 genomes of the carriers of the Omicron B.1.1.529 mutation in SARS-CoV-2 from South Africa, Asia, Massachusetts-USA, Rhode Island-USA, United Kingdom and Germany. All with 29,996pb extension and recovered from GENBANK and publicly available at the National Center for Biotechnology and Information (NCBI). All gaps and conserved sites were extracted for the construction of a phylogenetic tree and for specific methodologies of estimates of paired FST, Molecular Variance (AMOVA), Genetic Distance, Incompatibility, demographic expansion analyses, molecular diversity and of evolutionary divergence time analyses, always with 20,000 random permutations. The results revealed the presence of only 75 parsimony-informative sites, sites among the 29,996bp analyzed. The analyses based on FST values, confirmed the absence of distinct genetic structuring with fixation index of 98% and with a greater component of population variation (6%) for a "p" 0.05. Tau variations (related to the ancestry of the groups), did not reveal significant moments of divergence, supported by the incompatible analysis of the observed distribution ({tau} = 0%). It is safe to say that the large number of existing polymorphisms reflects major changes in the protein products of viral populations in all countries and especially In South Africa. This consideration provides the safety that, because there are large differences between the haplotypes studied, these differences are minimal within the populations analyzed geographically and, therefore, it does not seem safe to extrapolate the results of polymorphism and molecular diversity levels found in the Variant Omicron B.1.529 of SARS-CoV-2 for wild genomes or other mutants. This warns us that, due to their higher transmission speed and infection, possible problems of molecular adjustments in vaccines already in use may be necessary in the near future.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Infection, Genetics and Evolution
43 papers in training set
Top 0.1%
18.7%
2
PLOS ONE
4510 papers in training set
Top 13%
14.4%
3
Journal of Medical Virology
137 papers in training set
Top 0.1%
9.2%
4
Frontiers in Medicine
113 papers in training set
Top 0.4%
7.2%
5
Scientific Reports
3102 papers in training set
Top 14%
6.8%
50% of probability mass above
6
International Journal of Molecular Sciences
453 papers in training set
Top 4%
2.7%
7
Archives of Virology
14 papers in training set
Top 0.2%
2.6%
8
PeerJ
261 papers in training set
Top 5%
2.1%
9
Viruses
318 papers in training set
Top 2%
1.9%
10
International Journal of Infectious Diseases
126 papers in training set
Top 1%
1.9%
11
Gene Reports
13 papers in training set
Top 0.3%
1.7%
12
Heliyon
146 papers in training set
Top 2%
1.7%
13
Virus Research
36 papers in training set
Top 0.6%
1.5%
14
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 4%
1.3%
15
BioMed Research International
25 papers in training set
Top 2%
1.3%
16
Frontiers in Microbiology
375 papers in training set
Top 7%
1.2%
17
Frontiers in Genetics
197 papers in training set
Top 7%
1.2%
18
Pathogens
53 papers in training set
Top 1%
1.0%
19
Epidemiology and Infection
84 papers in training set
Top 3%
0.9%
20
F1000Research
79 papers in training set
Top 3%
0.9%
21
Access Microbiology
22 papers in training set
Top 0.6%
0.8%
22
Frontiers in Public Health
140 papers in training set
Top 7%
0.8%
23
Journal of Infection and Public Health
15 papers in training set
Top 0.7%
0.7%
24
Molecular Biology Reports
19 papers in training set
Top 0.6%
0.7%
25
Gene
41 papers in training set
Top 2%
0.7%
26
Journal of Clinical Virology
62 papers in training set
Top 0.9%
0.7%
27
Genomics
60 papers in training set
Top 3%
0.6%
28
Wellcome Open Research
57 papers in training set
Top 3%
0.6%
29
RSC Advances
18 papers in training set
Top 2%
0.6%
30
BMC Microbiology
35 papers in training set
Top 2%
0.5%